By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 25 August 2022 Photo: iStock/33karen33. The environment in which breast cancer arises –the interplay between the patient’s BMI, tumour size and cancer-specific proteins –is of importance for the prognosis. This is shown in a study from Lund University in Sweden. The knowledge could further enhance precision medicine in breast

https://www.medicine.lu.se/article/tumour-environment-can-affect-breast-cancer-prognosis - 2025-03-09

By katrin [dot] stahl [at] med [dot] lu [dot] se (Skånes universitetssjukhus och Medicinska fakulteten, Lunds universitet) - published 26 August 2022 Sandra Lindstedt, Snejana Hyllén, and Leif Pierre, Skåne University Hospital and Lund University. A large amount of lungs donated yearly cannot be used for transplantation. Researchers at Skåne University Hospital and Lund University have conducted a

https://www.medicine.lu.se/article/new-treatment-can-result-access-more-donor-lungs-and-fewer-complications-after-transplantations - 2025-03-09

By oscar [dot] heimburg [at] fsi [dot] lu [dot] se (Oskar Heimburg) - published 31 August 2022 Photo: Kennet Ruona. In November 2021, a private foundation was established to promote scientific research in pancreatic cancer, gastroenterology, and pain management at Lund University. The foundation will be endowed with a total of SEK 40 million and will be managed by Lund University. Earlier this spr

https://www.medicine.lu.se/article/sek-40-million-donation-faculty-medicine - 2025-03-09

Published 27 September 2022 Malin Parmar. Photo: Kennet Ruona. The Royal Swedish Academy of Sciences has elected two new members of the Academy’s class for medical sciences. One of them is Malin Parmar, Professor of Cellular Neuroscience at Lund University. Together with her research group, Malin Parmar has conducted several groundbreaking studies on stem cells that have led to the development of

https://www.medicine.lu.se/article/malin-parmar-elected-royal-swedish-academy-sciences - 2025-03-09

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 29 September 2022 Rita Charon, M.D. PhD, Professor and Executive Director of Columbia Narrative Medicine at Columbia University. Narrative medicine provides tools for clinicians to read patients better. 2022 Sandblom Prize Lecture will be given by pioneering Professor Rita Charon of Columbia University on the disci

https://www.medicine.lu.se/article/sandblom-prize-expanding-creativity-clinical-worlds-through-narrative-medicine - 2025-03-09

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 October 2022 Enming Zhang is measuring insulin secretion in islets of Langerhans from healthy human donors where the expression of Piezo1 has been blocked. Photo: Petra Olsson Impaired insulin secretion is closely associated with type 2 diabetes, but the process is not yet fully understood. A new study by researchers at

https://www.medicine.lu.se/article/study-shows-piezo1-ion-channel-plays-important-role-insulin-secretion - 2025-03-09

By alexis [dot] bento_luis [at] med [dot] lu [dot] se (Alexis Bento Luis) - published 18 October 2022 B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill. Uncovering how they form and are ‘programmed’ during development is key to better understanding the immune response to infections and vaccinations. A ne

https://www.medicine.lu.se/article/how-b-cells-are-programmed-early-life-can-impact-long-term-immune-health - 2025-03-09

By katrin [dot] stahl [at] med [dot] lu [dot] se (Katrin Ståhl) - published 26 October 2022 Göran Jönsson, Professor of Molecular Oncology, has been granted SEK 31 million from the Knut and Alice Wallenberg Foundation to improve the effect of immunotherapy in the treatment of cancer patients. About 30 percent of melanoma patients with metastatic disease benefit from immunotherapy. At the same time

https://www.medicine.lu.se/article/sek-31-million-more-effective-immunotherapy-cancer-treatment - 2025-03-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 1 November 2022 Photo: iStock/eyepark Locked fingers, known as trigger finger, are more common among people with diabetes than in the general population. A study led by Lund University in Sweden shows that the risk of being affected increases in the case of high blood sugar. The study has been published in Diabetes Care. Trigg

https://www.medicine.lu.se/article/hands-people-diabetes-more-often-affected-trigger-finger - 2025-03-09

By erika [dot] svantesson [at] med [dot] lu [dot] se (Erika Svantesson) - published 8 November 2022 The four medical students and the professor outside the cathedral. From left: Olha Zhurakivska, Oksana Tymoshchuk, Dariia Hrynevych, Viktoriia Bedei and Khrystyna Zhyhalo. Photo: Private. Professor Oksana Tymoshchuk came to Lund with her children as soon as the opportunity arose. She also wanted to

https://www.medicine.lu.se/article/ukrainian-medical-students-arrive-lund-after-lightning-fast-application-process - 2025-03-09

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 23 November 2022 Photo: iStock/baranozedemir A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms. It is now also possible to predict who will deteriorate within the next few years. The study is published in Nature Medici

https://www.medicine.lu.se/article/alzheimers-disease-can-be-diagnosed-symptoms-emerge - 2025-03-09

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 23 November 2022 Photo: iStock/kan2d Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to chemotherapy. The findings are significant for how future treatments should be designed. The results have been published in Science Advances. Neuro

https://www.medicine.lu.se/article/altered-cell-behaviour-behind-resistance-neuroblastoma - 2025-03-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 23 November 2022 Photo: iStock/mi-viri Sometimes healthcare professionals treat patients with opioids such as morphine to relieve symptoms, but there has been a lack of evidence as to whether this helps with severe chronic breathlessness. A randomised Phase 3 study conducted by Swedish and Australian researchers now finds that

https://www.medicine.lu.se/article/new-study-morphine-treatment-people-copd-and-severe-long-term-breathlessness - 2025-03-09

By katrin [dot] stahl [at] med [dot] lu [dot] se (Katrin Ståhl) - published 1 December 2022 Rita Charon and David Julius. Two world-leading American researchers known respectively for their research within medical humanities, and the sensory nervous system and perception of pain and temperature have been named honorary doctors at the Faculty of Medicine. The honorary doctorates will be conferred o

https://www.medicine.lu.se/article/honorary-doctors-named-faculty-medicine - 2025-03-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 12 December 2022 David Julius, Professor at the University of California, recipient of the Nobel Prize in Physiology or Medicine 2021, will be conferred an honorary doctorate from the Faculty of Medicine Lund University in May 2023. Photo: Paul Kennedy. Last year's Nobel celebration was a digital version, but this year David J

https://www.medicine.lu.se/article/his-interest-natural-products-led-nobel-prize - 2025-03-09

By anna [dot] hellgren [at] med [dot] lu [dot] se (Anna Hellgren) - published 16 December 2022 Kajsa M Paulsson, project director HALRIC Southern Scandinavia and Northern Germany form a leading life science region with unique research infrastructures that can help transform research into innovation. There is especially a large unused potential for industrial and clinical researchers to use these u

https://www.medicine.lu.se/article/11-million-euros-life-science-research-and-innovation-infrastructure-synergies-northern-europe - 2025-03-09

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 16 December 2022 Illustration of antibody binding mechanism The two arms of the antibody can bind to two different sites on a target protein. (Illustration: Wiley Editing Services) Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a

https://www.medicine.lu.se/article/antibody-discovery-paves-way-new-therapies-against-group-streptococcal-infections - 2025-03-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 2 January 2023 Johan Flygare and Aurélie Baudet, stem cell researchers at Lund University. Photo: Johan Persson. Stem cells programmed to produce insulin in people with type 1 diabetes or to repair the heart muscle after a heart attack. Gene and cell therapies that improve cancer treatments. These new and innovative therapies

https://www.medicine.lu.se/article/advanced-treatments-future-are-soon-here - 2025-03-09

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 23 January 2023 Immunology professor Lena Uller. Photo: Agata Garpenlind For risk groups, a common cold can be life-threatening. Researchers in Lund have contributed to the development of a new biological medicinal product to treat severe asthma that is worsened by colds. The hope is that the drug will be approved

https://www.medicine.lu.se/article/when-common-cold-becomes-life-threatening - 2025-03-09

By katrin [dot] stahl [at] med [dot] lu [dot] se (Katrin Ståhl) - published 24 January 2023 John Stegmayr. Photo: Katrin Ståhl The Lung Bioengineering and Regeneration research group is made up of about 15 researchers focusing on chronic lung disease. The group’s work includes the development of different methods to study disease models for conditions such as COPD and pulmonary fibrosis. One of th

https://www.medicine.lu.se/article/focusing-chronic-lung-disease - 2025-03-09